Author Correction: Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload
- PMID: 38355658
- PMCID: PMC10867024
- DOI: 10.1038/s41598-024-53947-8
Author Correction: Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload
Figures


Erratum for
-
Zinc nanoparticles ameliorated obesity-induced cardiovascular disease: role of metabolic syndrome and iron overload.Sci Rep. 2023 Sep 25;13(1):16010. doi: 10.1038/s41598-023-42550-y. Sci Rep. 2023. PMID: 37749096 Free PMC article.
Similar articles
-
Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study.Obes Surg. 2022 Jul;32(7):2438-2444. doi: 10.1007/s11695-022-06103-y. Epub 2022 May 11. Obes Surg. 2022. PMID: 35543890
-
Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload.Nanotoxicology. 2021 Aug;15(6):761-778. doi: 10.1080/17435390.2021.1919329. Epub 2021 May 7. Nanotoxicology. 2021. PMID: 33961538
-
Risk of Iron Overload in Obesity and Implications in Metabolic Health.Nutrients. 2021 May 2;13(5):1539. doi: 10.3390/nu13051539. Nutrients. 2021. PMID: 34063273 Free PMC article.
-
The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.Semin Vasc Med. 2002 Feb;2(1):45-57. doi: 10.1055/s-2002-23095. Semin Vasc Med. 2002. PMID: 16222595 Review.
-
[Iron deficiency and overload. Implications in oxidative stress and cardiovascular health].Nutr Hosp. 2010 May-Jun;25(3):350-65. Nutr Hosp. 2010. PMID: 20593115 Review. Spanish.
References
-
- El-Seidy AMA, Bashandy S, Ibrahim F, Abd El-Rahman S, Farid O, Moussa S, El-Baset M. Zinc oxide nanoparticles characterization and therapeutic evaluation on high fat/sucrose diet induced-obesity. Egypt. J. Chem. 2022;65(9):497–511. doi: 10.21608/ejchem.2022.112166.5113. - DOI
Publication types
LinkOut - more resources
Full Text Sources